Because many drug makers talk so much about emerging markets, and because prominent companies (Pfizer) are going to see U.S. salescontract, it is easy to forget that the U.S. drug market is still huge.
This morning, Kandi put those concerns to rest, with a s igned salescontract for 5, 000 mini-EVs to be delivered in between now and the end of the year .